Daxor Corporation to Participate in BIG10 Conference

Oak Ridge, TN, Sept. 08, 2026 /CourierPR/ -- Daxor Corporation, a global leader in blood volume measurement technology, will participate in the 10th Annual Lake Street Best Ideas Growth Conference (BIG10) in New York City on September 10, 2026. Michael Feldschuh, CEO and President of Daxor, will attend the event, where he will host one-on-one and small group meetings with investors.

The conference, organized by Lake Street, aims to highlight innovative growth opportunities in the healthcare sector. Daxor Corporation's involvement underscores its commitment to advancing precision in blood volume measurement, a critical aspect of patient care and treatment outcomes.

Daxor Corporation, headquartered in the United States, has a 50-year history of innovation and has developed the Blood Volume Analysis (BVA) diagnostic system. This patented technology offers real-time, precise data through a rapid, hand-held, and lab-based system. The BVA diagnostic is FDA-cleared and is designed to empower clinicians to make individualized treatment decisions, thereby improving patient outcomes and delivering substantial efficiencies in value-based healthcare.

The company is ISO certified and operates from a 20,000-square-foot state-of-the-art manufacturing facility, positioning Daxor for accelerated market expansion. The BVA diagnostic addresses the "multi-billion-dollar silent crisis" of imprecise blood volume measurement, which often leads to suboptimal care, prolonged hospital stays, and increased readmissions for conditions such as heart failure and intensive care unit (ICU) care.

Daxor Corporation's participation in the BIG10 Conference is an opportunity for the company to engage with key investors and share insights into its technology and market opportunities. The event is expected to attract a diverse group of attendees interested in exploring innovative solutions in healthcare.

Daxor's ongoing efforts to improve patient care through precise blood volume measurement are part of a broader strategy to enhance the efficiency and effectiveness of medical treatments. As the company continues to expand its market presence and product offerings, its participation in the BIG10 Conference highlights its commitment to driving innovation and delivering value to the healthcare sector.